메뉴 건너뛰기




Volumn 3, Issue 12, 2008, Pages

Non-natural and photo-reactive amino acids as biochemical probes of immune function

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE VACCINE; T LYMPHOCYTE RECEPTOR; WT1 PROTEIN; CROSS LINKING REAGENT; GAMMA INTERFERON; HISTOCOMPATIBILITY ANTIGEN; HLA A ANTIGEN; HLA A0201 ANTIGEN; HLA-A0201 ANTIGEN; PEPTIDE; UNCLASSIFIED DRUG;

EID: 58049208310     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003938     Document Type: Article
Times cited : (13)

References (38)
  • 1
    • 0025099787 scopus 로고
    • Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
    • Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520.
    • (1990) Cell , vol.60 , pp. 509-520
    • Call, K.M.1    Glaser, T.2    Ito, C.Y.3    Buckler, A.J.4    Pelletier, J.5
  • 2
    • 0025291908 scopus 로고
    • The candidate Wilms' tumour gene is involved in genitourinary development
    • Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, et al. (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197.
    • (1990) Nature , vol.346 , pp. 194-197
    • Pritchard-Jones, K.1    Fleming, S.2    Davidson, D.3    Bickmore, W.4    Porteous, D.5
  • 3
    • 0025644455 scopus 로고
    • Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor
    • Huang A, Campbell CE, Bonetta L, McAndrews-Hill MS, Chilton-MacNeill S, et al. (1990) Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science 250: 991-994.
    • (1990) Science , vol.250 , pp. 991-994
    • Huang, A.1    Campbell, C.E.2    Bonetta, L.3    McAndrews-Hill, M.S.4    Chilton-MacNeill, S.5
  • 4
    • 0030812823 scopus 로고    scopus 로고
    • The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro
    • Maurer U, Brieger J, Weidmann E, Mitrou PS, Hoelzer D, et al. (1997) The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. Exp Hematol 25: 945-950.
    • (1997) Exp Hematol , vol.25 , pp. 945-950
    • Maurer, U.1    Brieger, J.2    Weidmann, E.3    Mitrou, P.S.4    Hoelzer, D.5
  • 5
    • 0027328694 scopus 로고
    • The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma
    • Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, et al. (1993) The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 4: 415-420.
    • (1993) Nat Genet , vol.4 , pp. 415-420
    • Park, S.1    Schalling, M.2    Bernard, A.3    Maheswaran, S.4    Shipley, G.C.5
  • 6
    • 0025947718 scopus 로고
    • Expression of the Wilms' tumor gene WT1 in the murine urogenital system
    • Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, et al. (1991) Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev 5: 1345-1356.
    • (1991) Genes Dev , vol.5 , pp. 1345-1356
    • Pelletier, J.1    Schalling, M.2    Buckler, A.J.3    Rogers, A.4    Haber, D.A.5
  • 7
    • 0031048878 scopus 로고    scopus 로고
    • Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia
    • Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, et al. (1997) Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 89: 1405-1412.
    • (1997) Blood , vol.89 , pp. 1405-1412
    • Inoue, K.1    Ogawa, H.2    Sonoda, Y.3    Kimura, T.4    Sakabe, H.5
  • 8
    • 0028811234 scopus 로고
    • The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR
    • Brieger J, Weidmann E, Maurer U, Hoelzer D, Mitrou PS, et al. (1995) The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR. Ann Oncol 6: 811-816.
    • (1995) Ann Oncol , vol.6 , pp. 811-816
    • Brieger, J.1    Weidmann, E.2    Maurer, U.3    Hoelzer, D.4    Mitrou, P.S.5
  • 9
    • 0038011942 scopus 로고    scopus 로고
    • Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes
    • Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, et al. (2003) Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. J Clin Oncol 21: 1988-1995.
    • (2003) J Clin Oncol , vol.21 , pp. 1988-1995
    • Cilloni, D.1    Gottardi, E.2    Messa, F.3    Fava, M.4    Scaravaglio, P.5
  • 10
    • 0032992295 scopus 로고    scopus 로고
    • Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth
    • Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, et al. (1999) Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90: 194-204.
    • (1999) Jpn J Cancer Res , vol.90 , pp. 194-204
    • Oji, Y.1    Ogawa, H.2    Tamaki, H.3    Oka, Y.4    Tsuboi, A.5
  • 11
    • 0033966369 scopus 로고    scopus 로고
    • HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide
    • Ohminami H, Yasukawa M, Fujita S (2000) HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood 95: 286-293.
    • (2000) Blood , vol.95 , pp. 286-293
    • Ohminami, H.1    Yasukawa, M.2    Fujita, S.3
  • 12
    • 0034112824 scopus 로고    scopus 로고
    • Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product
    • Oka Y, Elisseeva OA, Tsuboi A, Ogawa H, Tamaki H, et al. (2000) Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics 51: 99-107.
    • (2000) Immunogenetics , vol.51 , pp. 99-107
    • Oka, Y.1    Elisseeva, O.A.2    Tsuboi, A.3    Ogawa, H.4    Tamaki, H.5
  • 13
    • 0034176750 scopus 로고    scopus 로고
    • Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1
    • Gao L, Bellantuono I, Elsasser A, Marley SB, Gordon MY, et al. (2000) Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 95: 2198-2203.
    • (2000) Blood , vol.95 , pp. 2198-2203
    • Gao, L.1    Bellantuono, I.2    Elsasser, A.3    Marley, S.B.4    Gordon, M.Y.5
  • 14
    • 0036451819 scopus 로고    scopus 로고
    • Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues
    • Tsuboi A, Oka Y, Udaka K, Murakami M, Masuda T, et al. (2002) Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues. Cancer Immunol Immunother 51: 614-620.
    • (2002) Cancer Immunol Immunother , vol.51 , pp. 614-620
    • Tsuboi, A.1    Oka, Y.2    Udaka, K.3    Murakami, M.4    Masuda, T.5
  • 15
    • 0037111734 scopus 로고    scopus 로고
    • Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL
    • Bellantuono I, Gao L, Parry S, Marley S, Dazzi F, et al. (2002) Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL. Blood 100: 3835-3837.
    • (2002) Blood , vol.100 , pp. 3835-3837
    • Bellantuono, I.1    Gao, L.2    Parry, S.3    Marley, S.4    Dazzi, F.5
  • 16
    • 8444248183 scopus 로고    scopus 로고
    • In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity
    • Doubrovina ES, Doubrovin MM, Lee S, Shieh JH, Heller G, et al. (2004) In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity. Clin Cancer Res 10: 7207-7219.
    • (2004) Clin Cancer Res , vol.10 , pp. 7207-7219
    • Doubrovina, E.S.1    Doubrovin, M.M.2    Lee, S.3    Shieh, J.H.4    Heller, G.5
  • 17
    • 12144291167 scopus 로고    scopus 로고
    • WT1 peptide-based immunotherapy for patients with lung cancer: Report of two cases
    • Tsuboi A, Oka Y, Osaki T, Kumagai T, Tachibana I, et al. (2004) WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases. Microbiol Immunol 48: 175-184.
    • (2004) Microbiol Immunol , vol.48 , pp. 175-184
    • Tsuboi, A.1    Oka, Y.2    Osaki, T.3    Kumagai, T.4    Tachibana, I.5
  • 18
    • 33745686444 scopus 로고    scopus 로고
    • A phase I/ II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data
    • Morita S, Oka Y, Tsuboi A, Kawakami M, Maruno M, et al. (2006) A phase I/ II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data. Jpn J Clin Oncol 36: 231-236.
    • (2006) Jpn J Clin Oncol , vol.36 , pp. 231-236
    • Morita, S.1    Oka, Y.2    Tsuboi, A.3    Kawakami, M.4    Maruno, M.5
  • 19
    • 4644289323 scopus 로고    scopus 로고
    • Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
    • Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, et al. (2004) Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci U S A 101: 13885-13890.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 13885-13890
    • Oka, Y.1    Tsuboi, A.2    Taguchi, T.3    Osaki, T.4    Kyo, T.5
  • 20
    • 0742324477 scopus 로고    scopus 로고
    • Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity
    • Mailander V, Scheibenbogen C, Thiel E, Letsch A, Blau IW, et al. (2004) Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity. Leukemia 18: 165-166.
    • (2004) Leukemia , vol.18 , pp. 165-166
    • Mailander, V.1    Scheibenbogen, C.2    Thiel, E.3    Letsch, A.4    Blau, I.W.5
  • 21
    • 33750291285 scopus 로고    scopus 로고
    • Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein
    • Pinilla-Ibarz J, May RJ, Korontsvit T, Gomez M, Kappel B, et al. (2006) Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein. Leukemia 20: 2025-2033.
    • (2006) Leukemia , vol.20 , pp. 2025-2033
    • Pinilla-Ibarz, J.1    May, R.J.2    Korontsvit, T.3    Gomez, M.4    Kappel, B.5
  • 22
    • 33747085478 scopus 로고    scopus 로고
    • Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules
    • Gomez-Nunez M, Pinilla-Ibarz J, Dao T, May RJ, Pao M, et al. (2006) Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules. Leuk Res 30: 1293-1298.
    • (2006) Leuk Res , vol.30 , pp. 1293-1298
    • Gomez-Nunez, M.1    Pinilla-Ibarz, J.2    Dao, T.3    May, R.J.4    Pao, M.5
  • 23
    • 0030934741 scopus 로고    scopus 로고
    • The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens
    • Herr W, Linn B, Leister N, Wandel E, Meyer zum Buschenfelde KH, et al. (1997) The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J Immunol Methods 203: 141-152.
    • (1997) J Immunol Methods , vol.203 , pp. 141-152
    • Herr, W.1    Linn, B.2    Leister, N.3    Wandel, E.4    Meyer zum Buschenfelde, K.H.5
  • 24
    • 34147119079 scopus 로고    scopus 로고
    • Synthetic anticancer vaccine candidates: Rational design of antigenic peptide mimetics that activate tumor-specific T-cells
    • Douat-Casassus C, Marchand-Geneste N, Diez E, Gervois N, Jotereau F, et al. (2007) Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells. J Med Chem 50: 1598-1609.
    • (2007) J Med Chem , vol.50 , pp. 1598-1609
    • Douat-Casassus, C.1    Marchand-Geneste, N.2    Diez, E.3    Gervois, N.4    Jotereau, F.5
  • 25
    • 0037039298 scopus 로고    scopus 로고
    • Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation
    • Kiick KL, Saxon E, Tirrell DA, Bertozzi CR (2002) Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation. Proc Natl Acad Sci U S A 99: 19-24.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 19-24
    • Kiick, K.L.1    Saxon, E.2    Tirrell, D.A.3    Bertozzi, C.R.4
  • 26
    • 0030959062 scopus 로고    scopus 로고
    • Comparison of the photochemical behavior of four different photoactivatable probes
    • Weber PJ, Beck-Sickinger AG (1997) Comparison of the photochemical behavior of four different photoactivatable probes. J Pept Res 49: 375-383.
    • (1997) J Pept Res , vol.49 , pp. 375-383
    • Weber, P.J.1    Beck-Sickinger, A.G.2
  • 27
    • 0024968835 scopus 로고
    • A general method for site-specific incorporation of unnatural amino acids into proteins
    • Noren CJ, Anthony-Cahill SJ, Griffith MC, Schultz PG (1989) A general method for site-specific incorporation of unnatural amino acids into proteins. Science 244: 182-188.
    • (1989) Science , vol.244 , pp. 182-188
    • Noren, C.J.1    Anthony-Cahill, S.J.2    Griffith, M.C.3    Schultz, P.G.4
  • 28
    • 0000652848 scopus 로고
    • Biosynthetic site-specific incorporation of a non-natural amino acid into a polypeptide
    • Bain JDGJ, Dix TA, Chamberlain AR, Diala ES (1989) Biosynthetic site-specific incorporation of a non-natural amino acid into a polypeptide. J Am Chem Soc 111: 8013-8014.
    • (1989) J Am Chem Soc , vol.111 , pp. 8013-8014
    • Bain, J.D.G.J.1    Dix, T.A.2    Chamberlain, A.R.3    Diala, E.S.4
  • 29
    • 0035811456 scopus 로고    scopus 로고
    • Peptide analogues of a subdominant epitope expressed in ebv-associated tumors: Synthesis and immunological activity
    • Marastoni M, Bazzaro M, Micheletti F, Gavioli R, Tomatis R (2001) Peptide analogues of a subdominant epitope expressed in ebv-associated tumors: synthesis and immunological activity. J Med Chem 44: 2370-2373.
    • (2001) J Med Chem , vol.44 , pp. 2370-2373
    • Marastoni, M.1    Bazzaro, M.2    Micheletti, F.3    Gavioli, R.4    Tomatis, R.5
  • 30
    • 0036311355 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues
    • Marastoni M, Bazzaro M, Micheletti F, Gavioli R, Tomatis R (2002) Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues. Bioorg Med Chem 10: 3061-3066.
    • (2002) Bioorg Med Chem , vol.10 , pp. 3061-3066
    • Marastoni, M.1    Bazzaro, M.2    Micheletti, F.3    Gavioli, R.4    Tomatis, R.5
  • 31
    • 0033168016 scopus 로고    scopus 로고
    • Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: Synthesis and binding affinity to a class I major histocompatibility complex protein
    • Poenaru S, Lamas JR, Folkers G, Lopez de Castro JA, Seebach D, et al. (1999) Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein. J Med Chem 42: 2318-2331.
    • (1999) J Med Chem , vol.42 , pp. 2318-2331
    • Poenaru, S.1    Lamas, J.R.2    Folkers, G.3    Lopez de Castro, J.A.4    Seebach, D.5
  • 32
    • 0032150303 scopus 로고    scopus 로고
    • Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705
    • Krebs S, Folkers G, Rognan D (1998) Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705. J Pept Sci 4: 378-388.
    • (1998) J Pept Sci , vol.4 , pp. 378-388
    • Krebs, S.1    Folkers, G.2    Rognan, D.3
  • 33
    • 33749578886 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLAB705
    • Jones MA, Hislop AD, Snaith JS (2006) Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLAB705. Org Biomol Chem 4: 3769-3777.
    • (2006) Org Biomol Chem , vol.4 , pp. 3769-3777
    • Jones, M.A.1    Hislop, A.D.2    Snaith, J.S.3
  • 34
    • 2542461354 scopus 로고    scopus 로고
    • Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue
    • Webb AI, Dunstone MA, Chen W, Aguilar MI, Chen Q, et al. (2004) Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue. J Biol Chem 279: 23438-23446.
    • (2004) J Biol Chem , vol.279 , pp. 23438-23446
    • Webb, A.I.1    Dunstone, M.A.2    Chen, W.3    Aguilar, M.I.4    Chen, Q.5
  • 35
    • 24744470278 scopus 로고    scopus 로고
    • T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo
    • Webb AI, Dunstone MA, Williamson NA, Price JD, de Kauwe A, et al. (2005) T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo. J Immunol 175: 3810-3818.
    • (2005) J Immunol , vol.175 , pp. 3810-3818
    • Webb, A.I.1    Dunstone, M.A.2    Williamson, N.A.3    Price, J.D.4    de Kauwe, A.5
  • 36
    • 0034609821 scopus 로고    scopus 로고
    • Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: Implications for recognition by tumor-infiltrating lymphocytes
    • Guichard G, Zerbib A, Le Gal FA, Hoebeke J, Connan F, et al. (2000) Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a beta-amino acid residue: implications for recognition by tumor-infiltrating lymphocytes. J Med Chem 43: 3803-3808.
    • (2000) J Med Chem , vol.43 , pp. 3803-3808
    • Guichard, G.1    Zerbib, A.2    Le Gal, F.A.3    Hoebeke, J.4    Connan, F.5
  • 37
    • 0030007650 scopus 로고    scopus 로고
    • Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2
    • Guichard G, Connan F, Graff R, Ostankovitch M, Muller S, et al. (1996) Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2. J Med Chem 39: 2030-2039.
    • (1996) J Med Chem , vol.39 , pp. 2030-2039
    • Guichard, G.1    Connan, F.2    Graff, R.3    Ostankovitch, M.4    Muller, S.5
  • 38
    • 0035060232 scopus 로고    scopus 로고
    • Synthesis and antigenic properties of reduced peptide bond analogues of an immunodominant epitope of the melanoma MART-1 protein
    • Quesnel A, Zerbib A, Connan F, Guillet JG, Briand JP, et al. (2001) Synthesis and antigenic properties of reduced peptide bond analogues of an immunodominant epitope of the melanoma MART-1 protein. J Pept Sci 7: 157-165.
    • (2001) J Pept Sci , vol.7 , pp. 157-165
    • Quesnel, A.1    Zerbib, A.2    Connan, F.3    Guillet, J.G.4    Briand, J.P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.